Brawn Biotech Ltd (530207) — Board Meeting | 1 September 2026
Brawn Biotech Ltd announced its 41st AGM on 29 September 2026 via video conferencing, with resolutions including re-appointment of Mr. Amit Kumar as Manager for 5 years at ₹9,76,512 annual remuneration and approval of director appointments. The filing confirms no material changes, no loans or investments under Section 186, no regulatory penalties, and compliance with SEBI exemptions due to small capital. Financials show a net loss of ₹9,406.18 lakhs for FY2025-26, though revenue grew to ₹169,777.32 lakhs. Cash reserves surged to ₹2,806.30 lakhs, and internal controls remain effective. Shareholders can e-vote from 26-28 September using NSDL or CDSL platforms.
About Brawn Biotech Ltd (530207)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 530207 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 530207 — Free💡 Ask AI about this filing
📊 More 530207 filings
No other filings yet.
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd